Two studies described de novo gene mutations involved in autism spectrum disorder and other neurodevelopmental conditions, while weeding out unrelated changes.
The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome.
GeneDx said it will contribute patient data and analytical tools to the UK's Deciphering Developmental Disorders study.
The Cognitive Genomics Consortium researchers said their findings could help understand how the brain works at the molecular level.
The results suggest that targeted treatments used in rare epilepsies might also work in a portion of patients with common forms of the disease.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.